Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure

Chest

Volumn 113, Issue 6, 1998, Pages 1604-1608

  Sahebjami, Hamid ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anaerobic metabolism; Sleep disorders; Uric acid excretion

Indexed keywords

APNEA; ARTICLE; CREATININE URINE LEVEL; FORCED EXPIRATORY VOLUME; NOSE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TISSUE OXYGENATION; URIC ACID URINE LEVEL;

EID: 0031802422     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.6.1604     Document Type: Article

References (34)

1. Fox IH. Metabolic basis for disorders of purine nucleotide degradation. Metabolism 1981; 30:616-34
2. Fox IH, Pallela TD, Kelly WN. Hyperuricemia: a marker for cell energy crisis. New Engl J Med 1987; 317:111-12
3. Van Bilsen M, van der Vusse GJ, Coumans WA, et al. Degradation of adenine nucleotides in ischemic and reperfused rat heart. Am J Physiol 1989; 257:H47-54
4. 2 formation during nucleotide degradation in the hypoxic rat liver: a quantitative approach. Free Radic Res Commun 1986; 1:289-95
5. Fox AC, Reed GE, Classman E, et al. Release of adenosine from human hearts during angina induced by rapid atrial pacing. J Clin Invest 1974; 53:1447-57
6. Fox AC, Reed GE, Meilmam H, et al. Release of nucleosides from canine and human hearts as an index of prior ischemia. Am J Cardiol 1979; 43:52-58
7. Jensen MH, Brinklov MM, Lillquist K. Urinary loss of oxypurines in hypoxic premature neonates. Biol Neonate 1980; 38:40-48
8. Jensen MH. The catabolism of purine nucleotides in the human organism [thesis]. Institute of Anaesthesiology, Odense University. Odense, Denmark: CAVI Bogtrykkeri, 1986
9. Ketai LH, Simon RH, Kreit JW, et al. Plasma hypoxanthine and exercise. Am Rev Respir Dis 1987; 136:98-101
10. Woolliscroft JO, Fox IH. Increased body fluid purine levels during hypotensive events: evidence for ATP degradation. Am J Med 1986; 81:472-78
11. Christensen EF, Jacobsen J, Anker-Moller E, et al. Increased urinary loss of uric acid in adults with acute respiratory failure requiring mechanical ventilation. Chest 1992; 102:556-59
12. Grum CM, Simon RH, Dantzker DR, et al. Evidence for adenosine triphosphate degradation in critically-ill patients. Chest 1985; 88:763-67
13. Hasday JD, Grum CM. Nocturnal increase of urinary uric acid:creatinine ratio: a biochemical correlate of sleep-associated hypoxemia. Am Rev Respir Dis 1987; 135:534-38
14. Braghiroli A, Sacco C, Erbetta M, et al. Overnight urinary uric acid:creatinine ratio for detection of sleep hypoxemia: validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis 1993; 148:173-78
15. McKeon JL, Saunders NA, Murree-Allen K, et al. Urinary uric acid:creatinine ratio, serum erythropoietin, and blood 2,3-diphosphoglycerate in patients with obstructive sleep apnea. Am Rev Respir Dis 1990; 142:8-13
16. Simkin PA, Hoover PL, Paxson CS, et al. Uric acid excretion: quantitative assessment from spot, midmorning serum and urine samples. Ann Intern Med 1979; 91:44-47
17. Ferris BG. Recommended standardized procedures for pulmonary function testing. Am Rev Respir Dis 1978; 118:55-88
18. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow volume curve with growth and aging. Am Rev Respir Dis 1983; 127:725-34
19. Goldman HI, Becklake MR. Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberculosis 1959; 79:457-67
20. Gaensler ISA, Smith AA. Attachment for automated single breath diffusing capacity measurement. Chest 1973; 63: 136-45
21. Javaheri S, Parker TJ, Wexler L, et al. Occult sleep disordered breathing in stable congestive heart failure. Ann Intern Med 1995; 122:487-92
22. Tietz NW. Clinical guide to laboratory tests. 2nd ed. Philadelphia: W.B. Saunders, 1990; 568
23. Snedecor GW, Cochran WC. Statistical methods. 7th ed. Ames, Iowa: Iowa State University Press, 1980; 193-95
24. Hedner J, Darpo B, Ejnel H, et al. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnea: cardiovascular implications. Eur Respir J 1995; 8:222-29
25. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-904
26. Smith ML, Niedermaier ON, Hardy SM, et al. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Syst 1996; 56:184-90
27. Dimsdale JE, Coy T, Anconi-Israel S, et al. Sympathetic nervous system alterations in sleep apnea: the relative importance of respiratory disturbances, hypoxia, and sleep quality. Chest 1997; 111:639-42
28. Montner PK, Greene R, Murata GH, et al. Hemodynamic effects of nasal and mask continuous positive airway pressure. Am J Respir Crit Care Med 1994; 149:1614-18
29. Schroeder JS, Motta J, Guilleminault C. Hemodynamic studies in sleep apnea. In: Guilleminault C, Dement WC, eds. Sleep apnea syndrome. New York: Alan R. Liss, 1978; 177-90
30. Guilleminault C, Motta J, Mihm F, et al. Obstructive sleep apnea and cardiac index. Chest 1986; 89:331-34
31. Krieger J, Laks L, Grunstein RR, et al. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnea before and during treatment with nasal continuous positive airway pressure. Clin Sci 1989; 77:407-11
32. Lin CC, Tsan KW, Lin CY. Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome. Sleep 1993; 16:37-39
33. Edwards BS, Zimmerman RS, Schwab TR, et al. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988; 62:191-95
34. Lew RA, Baertschi A. Mechanisms of hypoxia-induced atrial natriuretic factor release from rat heart. Am J Physiol 1989; 257:H147-H156